Latest / Bloomberg Law / Bloomberg Law Brief: Bayer-Monsanto Deal Delayed (Audio)
Transcript
- 0:00Speaker 1: Well, now is time for our daily Bloomberg Law Brief,
- 0:02Speaker 1: exploring legal issues in the news, and today Bloomberg Lajos
- 0:05Speaker 1: during Grosso and Michael Best discussed the reasons for a
- 0:08Speaker 1: delay and Buyer's plan sixties six billion dollar purchase of
- 0:12Speaker 1: mont Santo. You speak with Jennifer Rheas, senior litigation analysts
- 0:15Speaker 1: for Bloomberg Intelligence. Jen, what are the concerns with a
- 0:19Speaker 1: merger like this in the midst of an unprecedented wave
- 0:23Speaker 1: of consolidation in the agro chemicals industry. Well, I mean
- 0:27Speaker 1: you just said it. That's the first thing. You have
- 0:28Speaker 1: a lot of consolidation in the industry, and of course
- 0:31Speaker 1: this is more and both in the US and and EU,
- 0:34Speaker 1: there are concerns about farmers, which are the primary customers
- 0:37Speaker 1: of all of these companies down DuPont that just merged
- 0:39Speaker 1: out Buyer mont Santo, as well as KEM China and
- 0:42Speaker 1: cent Genta. So you know what the EU is concerned
- 0:44Speaker 1: about are some overlaps between these two companies, Buyer and
- 0:48Speaker 1: mont Santo in a couple different kinds of pesticides UM,
- 0:51Speaker 1: as well as in some seats UM. As well as
- 0:54Speaker 1: the possibility that this combined company could bundle these products,
- 0:58Speaker 1: both of which are sold to farmers, and there could
- 1:01Speaker 1: be some harm that could come out of that ability.
- 1:04Speaker 1: So Jen, what is buyer going to do with this
- 1:07Speaker 1: extra time, as it were, this delay in the takeover?
- 1:11Speaker 1: You know, I suspect and this is obviously just speculation
- 1:15Speaker 1: that what is happening is that they are working now
- 1:18Speaker 1: on negotiating remedies that they will have to agree to
- 1:22Speaker 1: with the EU in order to be able to close
- 1:24Speaker 1: their deal, and that they are they've decided that it's
- 1:28Speaker 1: worth it to them to have a little extra time
- 1:30Speaker 1: to try to make some arguments to limit what the
- 1:34Speaker 1: European regulators require them to sell off. And it's clear
- 1:37Speaker 1: they're going to have to sell assets, and they may
- 1:39Speaker 1: be simply trying to limit what it is they have
- 1:41Speaker 1: to sell there. And while they're discussing remedies with the regulators,
- 1:46Speaker 1: they're also holding talks with potential acquirers about some assets
- 1:52Speaker 1: that they may need to divest. It doesn't seem pretty
- 1:55Speaker 1: certain that the EU is going to require some substantial divestments.
- 2:00Speaker 1: I think so absolutely. You know, when they go into
- 2:02Speaker 1: a phase two and then in particular, we know that
- 2:05Speaker 1: some assets were offered up early on during the Phase
- 2:08Speaker 1: one by buyer in in the European Commission rejected that package.
- 2:13Speaker 1: So we do know that they expect investitures and I
- 2:15Speaker 1: think it will be extensive. And they did require down
- 2:18Speaker 1: and du Pont to divest assets um not seeds, but
- 2:21Speaker 1: several assets in the pesticide area, as well as Keim
- 2:24Speaker 1: China and Cententa to divest some chemicals in order to close.
- 2:27Speaker 1: And I think we should expect that plus seeds and
- 2:29Speaker 1: maybe more. Here as Jennifer Ree, a senior litigation analyst
- 2:33Speaker 1: for Bloomberg Intelligence, speaking with Bloomberg LA host Jun Grosso
- 2:36Speaker 1: and Michael Best. You can listen to Bloomberg Law weekdays
- 2:39Speaker 1: at one pm Wall Street Time here on Bloomberg Radio,
- 2:42Speaker 1: and that is this morning's Bloomberg Law bree. If you
- 2:44Speaker 1: can find more legal news at Bloomberg Law dot com
- 2:46Speaker 1: and Bloomberg BNA dot com. Attorneys will find exceptional legal
- 2:49Speaker 1: research and business development tools there as well. Visit Bloomberg
- 2:53Speaker 1: Law dot com and Bloomberg na dot com for more
- 2:56Speaker 1: information